Blog
ABPM bundling requirement to be delayed
DHSC, NHS England and Community Pharmacy England have agreed that the requirement to provide one Ambulatory Blood Pressure Monitoring (ABPM) consultation per month as part of the ‘bundling’ requirements to achieve Pharmacy First fixed monthly payment will not go ahead from 1st October 2025 as originally planned.
Adult Flu Season: Signing up to the correct PGD
Is your pharmacy ready for the eligible adults being able to access an NHS flu vaccination from the 1st October 2025?
MHRA Green Guide – 2025 Update?
Pharmacists need to check their Professional Indemnity Insurance to ensure that it covers them for the services they are providing, and to ensure that the level of cover is sufficient.
Communication from the GPhC regarding Regulatory Concerns
Communication from the GPhC regarding Regulatory Concerns Regarding the Supply and Promotion of Weight-Management Medicines – Mounjaro®, Wegovy® and Related GLP-1 Therapies
Professional Indemnity Insurance
Pharmacists need to check their Professional Indemnity Insurance to ensure that it covers them for the services they are providing, and to ensure that the level of cover is sufficient.
FDA Warning Letters
The MHRA has reviewed its current approach to contacting UK Licence Holders who may be implicated by USFDA Warning Letters
Emerging issues – Communique from the GPhC
As part of maintaining professional vigilance and regulatory compliance across pharmacy services, PCL would like to draw attention to several critical issues recently highlighted by the General Pharmaceutical Council (GPhC).
New MHRA/NICE Collaboration
The UK is entering a new phase of innovation in how it regulates, assesses, and adopts new medicines—and it’s a development the global pharmaceutical and biopharmaceutical industry cannot afford to overlook.
The Future of Pharmacy first
Pharmacists, remember to direct their virtual patients to the Pharmacy First Survey to leave their feedback on the service.
Pharmaceutical Wholesalers – an eclectic bunch
It is probably true that there are no two pharmaceutical wholesales that are the same, but the variation out there is also probably a little surprising.
What are the main requirements for controlled drugs?
As described in the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations (MDR) 2001, any company wishing to possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland will need to apply for a domestic licence – this includes where you are not physically handling but are directing and / or taking ownership.
FSN for Zoll Powerheart G5 AEDs
FSN (Field Safety Notice) for Zoll Powerheart G5 AEDs was issued by Zoll earlier this year for G5 AEDs that may display Error Code (EC) 501.